beta blocker

At multivariate backward stepwise analysis, in terms of the dependent variable of mortality in the ICU, max HR <100/ minute was identified as one of the two statistically independent variables among age, previous beta blocker use, beta blocker use in the ICU, hypotension, and CHARLSON and APACHE-II scores.

Atenolol is a beta blocker. It can cause the side effects that you mention.

Sixteen hypertensive patients (aged 45-64 years) being treated with a beta blocker (atenolol or metoprolol) were randomly assigned to receive, in double-blind fashion, 2.5 mg of melatonin or placebo each night for 3 weeks.

Of the 610 men who had hypertension or were being treated with medication for hypertension, 15 percent were taking a beta blocker alone, 18 percent were taking a beta blocker plus one or more other medications, and the remaining participants were taking other blood pressure medications.

In 1962 he came up with propranolol (Inderal), the first clinically successful beta blocker. It has since been joined by an array of more refined, selective beta blockers but the planned synthesis of propranolol based on the structure of specific neurotransmitters represents the turning point between drug discovery and drug design.

On page 24 in the paragraph concerning drugs that decrease GC production, Gregory Vogel refers to "the beta blocker verapamil." However, I wanted to inform you that verapamil is not a beta-blocker and, instead, is a calcium-channel blocker that produces its effects on the heart by blocking the transport of calcium into myocardial muscle cells, thus reducing excitability and contractility of the heart.

Dr Silas, from Wirral's Arrowe Park Hospital, and the rest of the team, spent five years looking at 9,000 people who took either a beta blocker or Losartan, along with a combination of other drugs.

Total mortality among women on a beta blocker was reduced by 30% compared with placebo, comparable to the 33% relative risk reduction seen in men.

Similarly, the risk of hospitalization for any cause was reduced by about 14% both in men and women on a beta blocker. Hospitalizations for worsening CHF were cut by 31%.

The beta blocker carvedilol (Coreg) was approved in May 1997 for heart failure.

Researchers at Penn State found that melanoma patients who received immunotherapy while taking a specific type of beta blocker lived longer than patients who received immunotherapy alone.

3 issue of the Journal of the American Medical Association (JAMA), found that beta blocker use is not associated with lower risks of heart attack, stroke and mortality.